Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) 17. March 2022, section EMCDDA news
16. February 2024 Technical dialogue on cannabis policies kicks off in Montevideo This week in Montevideo, the EMCDDA is co-organising with the Uruguayan Junta Nacional de Drogas, a technical dialogue on...